FGEN Competitors & Alternatives
Compare FibroGen Inc with similar stocks in the same industry
Biotechnology
FGEN
Main Stock$9.71
Tradestie Score
59
Market Cap
$48.63M
Revenue Growth
7.7%
Analyst Upside
+342.8%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$6.10
|
$158.43M | - | 48 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.31
|
$154.27M | - | 54 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$12.84
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.43
|
$114.01M | - | 50 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$26.78
|
$110.20M | - | 50 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$5.18
|
$71.69M | - | 46 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.52
|
$67.94M | - | 52 | Compare |
|
TPIC
TPIC
|
- | - | - | - | Compare |
|
AFMD
AFMD
|
- | - | - | - | Compare |
|
MEIP
MEIP
|
- | - | - | 49 | Compare |
More FGEN Analysis
Data updated: Jul 25, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry